Technical Data
Vascular Endothelial Growth Factor Receptor 1 (VEGF Receptor 1, VEGFR 1, VEGFR1, VEGFR-1, EC, FLT, Fms-like Tyrosine Kinase 1, Flt 1, Flt1, Flt-1, Fms Related Tyrosine Kinase 1, Fms-related Tyrosine Kinase 1 (Vascular Endothelial Growth Factor/Va
Angiogenesis, the formation of new blood vessels, is regulated by the balance between positive and negative endothelial regulatory factors. Vascular endothelial factor receptor-1 (VEGFR-1), also known as FMS-like tyrosine kinase 1 (Flt-1), is a transmembrane receptor tyrosine kinase with high affinity for vascular endothelial growth factor (VEGF) and placenta growth factor (PlGF). Binding of VEGF to VEGFR-1 produces receptor dimerization and subsequent signal transduction. Full length VEGFR-1 is characterized by the presence of seven extracellular immunoglobulin-like domains containing the ligand binding region, a single short transmembrane sequence and an intracellular region with a tyrosine kinase domain. VEGF receptors are expressed by vascular endothelial cells and peripheral blood monocytes, and have also been observed in colon carcinoma cell lines and colorectal cancer liver metastases. In addition to the full-length form of the receptor, a soluble form (sVEGFR-1 or sFlt-1) is generated by alternative splicing of Flt-1 mRNA. This naturally occurring, soluble form of VEGFR-1 is truncated on the C-terminal side of the sixth extracellular Ig-like domain, and has been described in various locations, including the serum and plasma of normal males and females, the serum of pregnant women, placenta, and breast tumor tissues. Soluble VEGFR-1 is an antagonist of VEGF action and an inhibitor of the VEGF signaling pathway, which has been characterized as one of the most important endothelial regulators in human tumor angiogenesis.

Suitable for use in Immunofluorescence, ELISA, Western Blot and Immunoprecipitation. Other applications not tested.

Recommended Dilutions:
ELISA: 1.5-8ug/ml
Western Blot: 1-10ug/ml
Immunoprecipitation: 1-5ug/ml lysate
Immunofluorescence (IC): 1:10-1:2000
Optimal dilutions to be determined by the researcher.

Storage and Stability:
Lyophilized powder may be stored at -20C. Stable for 12 months at -20C. Reconstitute with sterile ddH2O. Aliquot to avoid repeated freezing and thawing. Store at -20C. Reconstituted product is stable for 12 months at -20C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
MabIgG19F478Affinity Purified
100ug-20CBlue IceHumanMouse
~1mg/ml (after reconstitution)
Recombinant protein corresponding to human soluble extracellular Vascular Endothelial Growth Factor Receptor 1. Cellular Localization: Type I membrane protein and soluble
Purified by Protein G affinity chromatography.
Supplied as a lyophilized powder from PBS, pH 7.4. No preservatives added. Reconstitute with 100ul sterile ddH2O.
Recognizes the recombinant and naturally occurring form of human Vascular Endothelial Growth Factor Receptor 1 at ~150kD. Species Crossreactivity: mouse
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.